文献速递膀胱癌与上尿路尿路上皮癌

固有层浸润范围对接受卡介苗或根治性膀胱切除术的T1高级别非肌层浸润性膀胱癌患者的影响

Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
PubMed 文献 · BJU Int · 2024-02-19

该回顾性研究纳入2000至2020年间411例pT1高级别非肌层浸润性膀胱癌患者,评估固有层浸润范围(未注明、局灶/浅表、广泛/多灶)对接受卡介苗(BCG)或即刻根治性膀胱切除术(iRC)患者的预后价值。中位随访53个月,广泛/多灶浸润者更可能接受iRC(34% vs 19%,P=0.003);BCG治疗者中广泛/多灶浸润与进展独立相关(HR 5.3,95%CI 2.2-13.1,P<0.001),且MFS和CSS较差;T1亚分期与RC时升级无显著关联(OR 3.15,95%CI 0.82-12.12,P=0.095)。

要点

  • 411例pT1高级别患者中,广泛/多灶固有层浸润者占36.2%,更可能接受iRC(34% vs 19%,P=0.003)。
  • BCG治疗者中广泛/多灶浸润与进展独立相关(HR 5.3,95%CI 2.2-13.1,P<0.001)。
  • T1亚分期与RC时升级无显著关联(OR 3.15,95%CI 0.82-12.12,P=0.095)。

核心结论

  • 广泛/多灶固有层浸润与BCG治疗患者的无进展生存、无转移生存和癌症特异性生存较差相关。
  • T1亚分期提供有价值的预后信息,应报告于病理报告中。

研究设计与样本

  • 经机构审查委员会批准的回顾性研究,分析2000至2020年间接受BCG或iRC治疗的pT1非肌层浸润性膀胱癌患者。
  • 共纳入411例T1高级别患者,其中303例(73.7%)接受BCG,108例(26.3%)接受iRC。
  • 中位(四分位距)随访53(32-96)个月。

主要发现

  • 固有层浸润特征:未注明115例(28%),局灶/浅表147例(35.8%),广泛/多灶149例(36.2%)。
  • 广泛/多灶浸润者接受iRC的比例显著高于局灶/浅表者(34% vs 19%,P=0.003)。
  • BCG治疗者中广泛/多灶浸润的MFS和CSS较局灶/浅表者差,iRC治疗者中未观察到此差异。
  • BCG治疗者中41例发生进展,广泛/多灶浸润与进展独立相关(HR 5.3,95%CI 2.2-13.1,P<0.001)。
  • T1亚分期与RC时升级至>pT2无显著关联(OR 3.15,95%CI 0.82-12.12,P=0.095)。

临床怎么用

  • T1亚分期应报告于病理报告中以提供预后信息。
  • 广泛/多灶固有层浸润与BCG治疗患者较差的PFS、MFS和CSS相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the prognostic value of T1 substaging in patients treated with bacillus Calmette-Guérin (BCG) or immediate radical cystectomy (iRC). MATERIALS AND METHODS: We performed an institutional review board-approved retrospective study analysing non-muscle-invasive bladder cancer (NMIBC) patients with pT1 disease treated with either BCG or iRC between 2000 and 2020. Lamina propria (LP) invasion characteristics were extracted from the pathology report. The Kaplan-Meier method was used to calculate overall survival (OS), cancer-specific survival (CSS) and metastasis-free survival (MFS). Multivariable Cox models were used to determine the association between progression-free survival (PFS) and characteristics in the BCG cohort. A logistic regression model explored the relationship between T1 substaging and upstaging to >pT2 at iRC. RESULTS: A total of 411 T1 high-grade patients were identified. LP invasion characteristics were as follows: not specified: 115 (28%); focal/superficial (F/S): 147 (35.8%); and extensive/multifocal (E/M): 149 (36.2%). Overall, 303 patients (73.7%) received BCG, and 108 patients (26.3%) underwent iRC. The median (interquartile range) follow-up was 53 (32-96) months. Patients with E/M LP invasion were significantly more likely to undergo iRC (34% vs. 19%; P = 0.003). Patients with E/M LP invasion showed poorer MFS and CSS compared to those with F/S LP invasion when treated with BCG but not when treated with iRC. Among BCG-treated patients, progression occurred in 41 patients and E/M LP invasion was independently associated with progression after BCG (hazard ratio 5.3, 95% confidence interval [CI] 2.2-13.1; P < 0.001). T1 substaging was not associated with upstaging at RC (odds ratio 3.15, 95% CI 0.82-12.12; P = 0.095). CONCLUSIONS: Extensive/multifocal LP invasion was associated with poor PFS, MFS and CSS in patients treated with BCG. T1 substaging provides valuable prognostic information and should be reported in pathology reports.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Contieri R, Tan WS, Grajales V, et al. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU Int. 2024. PMID: 38374533. doi:10.1111/bju.16293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。